Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Perspective of the European Cystic Fibrosis Society on Improving Global Cystic Fibrosis Care.

Pediatric pulmonology·2026

Same author

Cystic fibrosis nutrition: Addressing emerging trends following the 2024 ESPEN-ESPGHAN-ECFS guidelines. Expert opinion recommendations.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026

Same author

Partnership between cystic fibrosis centres in Europe: The Twinning Project.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026

Same author

Deeper understanding of healthcare system "overwhelm" during covid-19 is essential for coherent pandemic strategy.

BMJ (Clinical research ed.)·2026

Same author

Giardiasis in Japan, the United States of America, and Europe from 2007 to 2023, highlighting a decline during the COVID-19 pandemic.

PLoS neglected tropical diseases·2026

Same author

Implementation of a One Health Surveillance System in the Democratic Republic of the Congo.

EcoHealth·2026

Search research articles

Related Experiment Video

Updated: Jul 1, 2025

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance

Published on: June 14, 2024

Antibiotic prophylaxis for leptospirosis.

Tin Zar Win¹, Tanaraj Perinpanathan^1,2, Patrick Mukadi^3,4,5

¹School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.

The Cochrane Database of Systematic Reviews

|March 14, 2024

Summary

This summary is machine-generated.

Antibiotic prophylaxis for leptospirosis (a global zoonotic disease) shows uncertain benefits and may increase non-serious adverse events. More rigorous data is needed to confirm efficacy and safety for preventing this infection.

More Related Videos

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins

Published on: July 1, 2011

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira

Published on: August 14, 2021

Related Experiment Videos

Last Updated: Jul 1, 2025

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance

Published on: June 14, 2024

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins

Published on: July 1, 2011

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira

Published on: August 14, 2021

Area of Science:

Infectious Diseases
Public Health
Clinical Pharmacology

Background:

Leptospirosis is a significant global zoonotic and waterborne disease caused by pathogenic Leptospira species.
Antibiotic prophylaxis is a strategy for preventing leptospirosis, particularly for travelers and high-risk populations.
The clinical benefits and potential adverse effects of antibiotic prophylaxis for leptospirosis remain largely unknown.

Conclusions:

There is insufficient high-quality evidence from RCTs to support the routine use of antibiotics for leptospirosis prophylaxis.
The potential benefits of antibiotic prophylaxis for leptospirosis are unclear, and there is uncertainty regarding an increased risk of non-serious adverse events.
More rigorous research focusing on clinically relevant outcomes is needed to establish the role of antibiotic prophylaxis in preventing leptospirosis.